FX Conferences is proud to be the leader in providing convenient distance learning opportunities designed for busy professionals. We partner with leading industry experts to bring you key information and guidance on the latest challenges and hot topics, and our audio conference format makes it easy to participate from the office, at home or on the road. Feel free to browse through our list of coming events, or use our search feature to review past live presentations now available as recordings.

Search By
Industry
Department

Alliance Management - Narrowing the Divide Between Drugs and Diagnostics


Audio conference highlights


Alliance management has long been a core competency in many drug companies, as a way of helping to ensure that compounds discovered by biotech partners make their way to the market. Yet the relationship between drug and diagnostics companies has been a challenge for both sides. Understanding how to manage these strategic relationships is critical to the successful development of a companion diagnostic test, and there can be consequences for a drug company not taking an active role in these alliances.


In this audio conference presentation, our speaker examines the issue, and discusses when and how to start looking for a diagnostics partner, how to structure the relationship, and how best to work together for mutual benefit.


This audio conference covers:


  • What to look for in a good diagnostics partner
  • Understanding when to start the strategic relationship
  • Identifying what milestones should be in the contract, and when are they required
  • Tools for integrating the drug and diagnostic development processes


About the speaker:


David Kern, RAC MBA is Senior Director with Myraqa, a full-service IVD regulatory consulting firm. Dave has nearly 20 years of experience developing IVD and life science products. His experience in product development, project management, business development and relationship management grants him a wide view of the entire life-cycle management process. He has designed and implemented product development processes for both FDA and ISO environments, in both large and small companies. He also has extensive experience in creating and implementing governance structures to manage co-development and outsourcing relationships within both the IVD and therapeutics industries.


Dave holds a BS in Biochemistry from San Francisco State University, and a MBA from San Jose State University. He has extensive training in project management, facilitation and conflict resolution, and holds a Regulatory Affairs Certification.


Who should attend?


  • Regulatory Affairs
  • Quality
  • Clinical Affairs
  • Development Directors
  • Marketing Directors
  • Business Development Directors


Product Details

David Kern, RAC MBA
Alliance Management - Narrowing the Divide Between Drugs and Diagnostics
Title: Senior Director, Myraqa
Other Events: David Kern, RAC MBA
Duration: 60 minutes
Event Type: Previously recorded on 2011-07-12
Item #: ac20110712
12 Jul 2011 
Registration Price:
$249.00

Order Info

Select Order Type:  
Include Transcript With Order?:  
Quantity
More
Less
 
 
Bookmark and Share reviews

Reviews

Average Rating: (based on 1 review)

Showing 1 Review:

by P.L.
Director, Regulatory Affairs
The importance of proper (professional) alliance management become clear. During the presentation there was a good balance of general issues and the speakers own experiences. A bit more on the gap between drugs and diagnostics could been included. The Q&A session was good and useful.
Rate this item
© Copyright 2012
FXConferences.
All rights reserved.

FAQ  |  Medical Translation  |  Search  |  Privacy  |  Terms of Use  |  Contact